3 Drug Stocks Poised to Surpass Estimates in Q2 Earnings
August 08, 2017 at 15:32 PM EDT
The pharma/biotech sector has picked up pace this year after being battered by the drug pricing controversy in 2016. The first half has been pretty strong for companies in the space.